Merck Singulair labeling
Executive Summary
Merck's leukotriene receptor antagonist Singulair (montelukast) on Aug. 2 adds "very rarely pancreatitis; myalgia including muscle cramps; increased bleeding tendency, bruising; and edema" to the postmarketing adverse events section of labeling